Sensata Technologies Holding PLC (ST) Stock News

A securities class action lawsuit has been filed against UWM Holdings Corporation for allegedly making materially false and misleading statements regarding its mortgage servicing rights (MSRs) hedging strategy and hedge position related to the Two Harbors transaction. The lawsuit claims the company deviated from its traditional non-hedging strategy, over-hedged its position, and created excess hedging risk while making positive statements about its business. Investors with losses exceeding $100K who purchased securities between March 9, 2026 and August 5, 2026 have until October 13, 2026 to seek appointment as lead plaintiff.

A class action lawsuit has been filed against Duolingo, Inc. alleging that the company made false statements about Daily Active User growth while deliberately adding friction through increased ads and subscription upsells. The lawsuit covers stock purchases between May 2, 2025 and February 26, 2026. Duolingo's stock declined significantly following revelations of slowing DAU growth (from 49% to 30%) and a strategic shift away from monetization, with stock falling 25%, 8.5%, and 14% on three separate disclosure dates.

A securities class action lawsuit has been filed against XTI Aerospace, Inc. for allegedly making materially false and misleading statements regarding undisclosed senior executive activities, Board review procedures, and disclosure controls. Investors who purchased XTIA securities between April 15, 2026 and August 17, 2026 have until October 27, 2026 to seek appointment as lead plaintiff.

Kirby McInerney LLP has filed a securities fraud class action lawsuit against Endava plc on behalf of investors who purchased securities between September 4, 2025 and September 21, 2026. The lawsuit alleges that Endava made false and misleading statements regarding accounting treatment of customer and supplier agreements, failed to disclose delays in financial results, and concealed doubts about internal control effectiveness. The company's CFO was placed on administrative leave following an investigation by independent counsel. Endava's stock price declined 24.37% following the announcement.

Kirby McInerney LLP has filed securities fraud class action lawsuits against Anavex Life Sciences Corp. for allegedly making false statements and failing to disclose inadequate internal controls and regulatory challenges related to former CEO Christopher Missling's misconduct. The lawsuit covers investors who purchased securities between November 26, 2025 and August 28, 2026. Anavex's stock declined significantly following disclosures about the CEO's termination, delayed SEC filings, and material weaknesses in internal controls.

AST SpaceMobile (ASTS) declined 3.91% on October 7, 2026, underperforming the broader market. The stock has dropped 4.54% over the past month, lagging the S&P 500's 1.4% gain. While revenue is projected to grow 206.56% year-over-year to $45.19 million, the company is expected to report a loss of $0.39 per share. ASTS holds a Zacks Rank #4 (Sell) rating, and its Wireless Equipment industry ranks in the bottom 29% of all industries.

A Delaware federal court ruled on September 30, 2026, that Liquidia Corporation's lead product Yutrepia inhalation powder infringed two claims of United Therapeutics' patent for treating pulmonary hypertension. The ruling triggered a sharp 57.2% stock price decline from $70.69 to $30.26 per share. Liquidia's CEO stated the company plans to pursue appellate options. A law firm is now investigating potential securities law violations on behalf of stockholders.

Block & Leviton is investigating Millrose Properties for potential securities fraud, alleging the company misled investors about its business dealings with Lennar. A report claimed Millrose purchased approximately $200 million of finished Lennar homes at above retail prices and is renting them at a loss. The stock declined following the report and a subsequent analyst downgrade.

State Street Corporation is expected to report Q3 2026 earnings of $3.64 per share, representing a 30.9% year-over-year increase, with revenues projected at $4.04 billion (up 14%). The company has a positive Earnings ESP of +0.58% combined with a Zacks Rank #3 (Hold), suggesting it is likely to beat consensus estimates. State Street has beaten EPS estimates in all four of the last quarters, with the most recent quarter delivering a +10.61% surprise.

Novartis will present Phase III REMODEL-1/-2 trial results for remibrutinib, an oral BTK inhibitor for relapsing multiple sclerosis, at MSToronto2026. The company will also showcase expanded evidence for Kesimpta (ofatumumab) across multiple studies including pediatric MS, treatment-naive patients, and pregnancy/breastfeeding outcomes. An investor call will follow the remibrutinib data presentation.

Netlist (NLST) stock jumped 17.9% following a settlement with Micron that includes a $600 million five-year patent license deal and a $10 million share purchase. The company also previously announced a similar strategic alliance with Samsung. Expected earnings growth of 3100% and revenue growth of 630.8% support the move, though earnings estimate revisions remain unchanged.

Pomerantz LLP is investigating Deep Fission, Inc. for potential securities fraud following an Iceberg Research short report claiming the company's underground borehole reactor technology was overhyped and unlikely to achieve commercial viability. The stock fell 10.9% to $6.95 per share after the report's publication on September 26, 2026, just over three months after the company's IPO at $16.00 per share.

Pomerantz LLP is investigating potential securities fraud claims against Flutter Entertainment plc following the company's announcement on September 28, 2026, that it ceased operations in Brazil due to a nationwide online gaming ban. The news triggered a 7.93% stock price decline, with Flutter projecting approximately $70 million in lost 2026 revenue and $20 million reduction in adjusted EBITDA from the Brazilian unit closure.

Pomerantz Law Firm has filed a class action lawsuit against Fluence Energy, Inc. (NASDAQ: FLNC) alleging securities fraud and unlawful business practices. The lawsuit follows a series of disappointing financial announcements in 2026, including declining gross profit margins, significant revenue misses, and multiple guidance cuts totaling $1 billion in revenue reductions. The company's stock price fell dramatically following each announcement, dropping from $18.95 to $7.66 per share between February and September 2026. Investors have until November 30, 2026, to request Lead Plaintiff status.

Pomerantz LLP is investigating potential securities fraud claims against AirSculpt Technologies following a significant stock price decline of 45.11% on August 10, 2026, after the company reported lower-than-expected quarterly revenue of $42.9 million, down from $44.0 million year-over-year.

Pomerantz LLP is investigating potential securities fraud claims against Sionna Therapeutics following the company's August 10, 2026 announcement that its PreciSION CF Phase 2a trial failed to achieve its key activity endpoint. The failure to demonstrate efficacy of SION-719 when combined with Trikafta resulted in a dramatic 91.18% stock price decline, falling from approximately $51.04 to $4.50 per share.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Papa John's International (PZZA) on behalf of investors who purchased stock between August 7, 2025 and August 5, 2026. The lawsuit alleges that Papa John's made materially false and misleading statements about its transformation efforts, which were taking longer than expected and failed to prevent market share losses, requiring a shift toward increased promotional efforts.

Pomerantz LLP has launched investigations into potential securities fraud and unlawful business practices at Securitize Corp., Fluence Energy, Inc., and AirSculpt Technologies, Inc. The law firm is seeking investors who suffered losses to join class action lawsuits against these companies.

Pomerantz LLP is investigating potential securities fraud claims against Abeona Therapeutics following the company's August 13, 2026 disclosure that only four of five patient treatments with ZEVASKYN were recognized for revenue due to one batch lacking minimum sheet requirements. The announcement triggered a 14.95% stock price decline.

Pomerantz LLP is investigating potential securities fraud claims against LENZ Therapeutics following disappointing Q2 2026 earnings. The company reported flat organic product sales of $1.73 million for its primary eye drop VIZZ, with most revenue ($3.8M of $5.5M total) coming from one-time licensing milestones. Bank of America subsequently downgraded the stock from 'Buy' to 'Neutral' and slashed its price target from $31 to $7, citing slower-than-expected commercial launch performance.

Pomerantz LLP is investigating potential securities fraud claims against J.B. Hunt Transport Services following the company's September 16, 2026 warning of a 5-10% sequential earnings decline in Q3 2026. The decline was attributed to rising diesel fuel prices and a $25 million unexpected surge in driver expenses. The announcement triggered a 13.3% stock price drop, falling $36.52 to $236.73 per share.

Pomerantz Law Firm has filed a class action lawsuit against Endava Plc, alleging securities fraud and unlawful business practices. The lawsuit follows Endava's announcement that CFO Mark Thurston was placed on administrative leave pending an investigation into accounting treatment concerns raised by the company's auditors. Endava's stock price fell 24.37% on the news. The deadline to join the class action is November 30, 2026.

Pomerantz LLP is investigating securities fraud claims against EyePoint, Inc. following the company's announcement that its Phase 3 clinical trial for DURAVYU failed to meet its primary endpoint against Regeneron's Eylea. The stock plummeted 66.98% to $4.87 per share on August 17, 2026.

Pomerantz Law Firm has filed class action lawsuits against Papa John's International and Endava Plc, and is investigating claims against J.B. Hunt Transport Services. Papa John's stock fell 17.18% after announcing an 8.3% decrease in North American comparable sales, dividend suspension, and reduced 2026 guidance. Investors with losses are urged to contact the firm by November 2, 2026.

Pomerantz LLP is investigating Zscaler, Inc. for potential securities fraud following two significant stock price declines. The first occurred on May 27, 2026, when the stock fell 31.52% after the company issued lower-than-expected guidance for current-quarter revenue. The second decline of 10.06% happened on September 25, 2026, following the announcement of Chief Revenue Officer Mike Rich's departure. Investors are invited to join the class action lawsuit.

Steel Dynamics stock declined 1.19% on October 6, 2026, underperforming the broader market despite positive earnings forecasts. The company is expected to report Q3 EPS of $5.44 (up 98.54% YoY) and revenue of $6.13 billion (up 27.01% YoY) on October 19. With a Zacks Rank of #3 (Hold) and a Forward P/E of 13.61, the stock carries a neutral outlook despite strong fundamental growth expectations.

Ouster, Inc. (OUST) closed at $44.91, up 1.79% and outperforming the S&P 500's 0.58% gain. The stock has surged 21.11% over the past month. Analysts project quarterly EPS of -$0.3 and revenue of $56.2 million (up 42.17% YoY), with full-year estimates at -$1.05 EPS and $222.1 million revenue. The company holds a Zacks Rank #3 (Hold) rating with unchanged consensus estimates over the last 30 days.

Upstart Holdings (UPST) declined 2.01% to $23.86, underperforming the S&P 500's 0.58% gain. The company is anticipated to report Q earnings of $0.6 EPS (up 15.38% YoY) and revenue of $364.63 million (up 31.58% YoY). Full-year consensus estimates project $2.2 EPS and $1.42 billion revenue. However, UPST holds a Zacks Rank #4 (Sell) rating with a Forward P/E of 11.07, trading at a discount to its industry average.

Constellation Brands reported Q2 revenue of $2.63 billion, up 6.1% year-over-year and beating consensus estimates by 2.46%. EPS of $3.74 exceeded the $3.62 estimate by 3.32%. Wine and Spirits sales surged 17.2% while Beer sales grew 5.5%. However, the stock has declined 11.6% over the past month and carries a Zacks Rank #3 (Hold) rating.

Pomerantz LLP announced investigations into potential securities fraud and unlawful business practices at OSI Systems, lululemon athletica, and Ultragenyx Pharmaceutical. The investigation into OSI was triggered by the company's August 20, 2026 earnings report that missed revenue expectations due to deferred product deliveries, resulting in a 5.21% stock price decline.